Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Uhl

Showing results (251-260 of 526) with videos related to

Pageof 53
Sort By:
Brain Research|October 13, 2007
Deletion of v7-3 (SLC6A15) transporter allows assessment of its roles in synaptosomal proline uptake, leucine uptake and behaviorsJana Drgonova, Qing-Rong Liu, F Scott Hall, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|November 14, 2006
Addiction molecular genetics: 639,401 SNP whole genome association identifies many "cell adhesion" genesQing-Rong Liu, Tomas Drgon, Catherine Johnson, et al.
Human Molecular Genetics|April 15, 2005
SLC18A2 promoter haplotypes and identification of a novel protective factor against alcoholismZhicheng Lin, Donna Walther, Xiao-Ying Yu, et al.
Neuroscience|April 20, 2005
Mouse brain localization of the protein kinase C-enhanced phosphatase 1 inhibitor KEPI (kinase C-enhanced PP1 inhibitor)J-P Gong, Q-R Liu, P-W Zhang, et al.
Biophysical Journal|January 1, 1982
ESR spin-label studies of lipid-protein interactions in membranesD Marsh, A Watts, R D Pates, et al.
Brain Research. Molecular Brain Research|October 16, 1999
Heterozygous VMAT2 knockout mice display prolonged QT intervals: possible contributions to sudden deathK Itokawa, I Sora, C W Schindler, et al.
The Journal of Comparative Neurology|July 22, 1999
Cholinergic axon terminals in the ventral tegmental area target a subpopulation of neurons expressing low levels of the dopamine transporterM Garzón, R A Vaughan, G R Uhl, et al.
The Journal of Biological Chemistry|November 20, 1997
Mu opioid receptor phosphorylation, desensitization, and ligand efficacyY Yu, L Zhang, X Yin, et al.
Experimental and Clinical Psychopharmacology|April 4, 1998
Parkinsonian patients report blunted subjective effects of methylphenidateA M Persico, S Reich, J E Henningfield, et al.
Neuroscience|February 18, 1998
Medial prefrontal cortical injections of c-fos antisense oligonucleotides transiently lower c-Fos protein and mimic amphetamine withdrawal behavioursA M Persico, C W Schindler, S C Davis, et al.
Pageof 53

Showing results (251-260 of 526) with videos related to

Sort By:
Pageof 53
Brain Research|October 13, 2007
Deletion of v7-3 (SLC6A15) transporter allows assessment of its roles in synaptosomal proline uptake, leucine uptake and behaviorsJana Drgonova, Qing-Rong Liu, F Scott Hall, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|November 14, 2006
Addiction molecular genetics: 639,401 SNP whole genome association identifies many "cell adhesion" genesQing-Rong Liu, Tomas Drgon, Catherine Johnson, et al.
Human Molecular Genetics|April 15, 2005
SLC18A2 promoter haplotypes and identification of a novel protective factor against alcoholismZhicheng Lin, Donna Walther, Xiao-Ying Yu, et al.
Neuroscience|April 20, 2005
Mouse brain localization of the protein kinase C-enhanced phosphatase 1 inhibitor KEPI (kinase C-enhanced PP1 inhibitor)J-P Gong, Q-R Liu, P-W Zhang, et al.
Biophysical Journal|January 1, 1982
ESR spin-label studies of lipid-protein interactions in membranesD Marsh, A Watts, R D Pates, et al.
Brain Research. Molecular Brain Research|October 16, 1999
Heterozygous VMAT2 knockout mice display prolonged QT intervals: possible contributions to sudden deathK Itokawa, I Sora, C W Schindler, et al.
The Journal of Comparative Neurology|July 22, 1999
Cholinergic axon terminals in the ventral tegmental area target a subpopulation of neurons expressing low levels of the dopamine transporterM Garzón, R A Vaughan, G R Uhl, et al.
The Journal of Biological Chemistry|November 20, 1997
Mu opioid receptor phosphorylation, desensitization, and ligand efficacyY Yu, L Zhang, X Yin, et al.
Experimental and Clinical Psychopharmacology|April 4, 1998
Parkinsonian patients report blunted subjective effects of methylphenidateA M Persico, S Reich, J E Henningfield, et al.
Neuroscience|February 18, 1998
Medial prefrontal cortical injections of c-fos antisense oligonucleotides transiently lower c-Fos protein and mimic amphetamine withdrawal behavioursA M Persico, C W Schindler, S C Davis, et al.
Pageof 53